statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Medivir to present updated clinical data for fostrox + Lenvima in HCC at ESMO Conference in September

Medivir to present updated clinical data for fostrox + Lenvima in HCC at ESMO Conference in September Medivir to present updated clinical data for fostrox + Lenvima in HCC at ESMO Conference in...

Number of shares and votes in Medivir AB on 28 June 2024

Number of shares and votes in Medivir AB on 28 June 2024 Number of shares and votes in Medivir AB on 28 June 2024 PR Newswire STOCKHOLM, June 28, 2024 STOCKHOLM, June 28, 2024 /PRNewswire/ -- Medivir...

Fostrox + Lenvima holds promise of greatly improved outcomes for advanced liver cancer patients, reveals new data from Medivir at ESMO GI

Fostrox + Lenvima holds promise of greatly improved outcomes for advanced liver cancer patients, reveals new data from Medivir at ESMO GI Fostrox + Lenvima holds promise of greatly improved outcomes...

Medivir selects global CRO partner for upcoming phase 2b study in HCC with fostrox + Lenvima and initiates study feasibility

Medivir selects global CRO partner for upcoming phase 2b study in HCC with fostrox + Lenvima and initiates study feasibility Medivir selects global CRO partner for upcoming phase 2b study in HCC with...

Medivir to present at Redeye Growth Day

Medivir to present at Redeye Growth Day Medivir to present at Redeye Growth Day PR Newswire STOCKHOLM, May 30, 2024 STOCKHOLM, May 30, 2024 /PRNewswire/ -- Medivir AB (NASDAQ: MVIR) (STOCKHOLM...

Medivir to present data for the combination of fostrox + Lenvima in HCC at ESMO GI

Medivir to present data for the combination of fostrox + Lenvima in HCC at ESMO GI Medivir to present data for the combination of fostrox + Lenvima in HCC at ESMO GI PR Newswire STOCKHOLM, April 29...

FDA grants Medivirs MIV-711 Rare Pediatric Disease Designation and Orphan Drug Designation for the treatment of Legg-Calv-Perthes Disease

FDA grants Medivirs MIV-711 Rare Pediatric Disease Designation and Orphan Drug Designation for the treatment of Legg-Calv-Perthes Disease FDA grants Medivirs MIV-711 Rare Pediatric Disease...

Medivir's partner Vetbiolix announces positive results from Proof-of-Concept study with VBX-1000, previously known as MIV-701

Medivir's partner Vetbiolix announces positive results from Proof-of-Concept study with VBX-1000, previously known as MIV-701 Medivir's partner Vetbiolix announces positive results from...

52-Wk High	$0.00
52-Wk Low	$0.00

MVIR MultiVir

About

Feed

News

Fundamentals